Glazer Capital’s Frazier Lifesciences Acquisition Corp Warrant FLACW Stock Holding History
Bought
Maintained
Sold
Other funds holding FLACW
Glazer Capital's FLACW Position: Q2 2022 in Review
Glazer Capital sold out of Frazier Lifesciences Acquisition Corp Warrant (FLACW) in Q2 2022, closing a stake of 36,150 shares — an estimated $6K sold.
Glazer Capital first reported a position in FLACW in Q4 2021 and held it in 2 quarters. The position peaked at $26K in Q4 2021. 30 funds tracked by Wall St. Rank hold FLACW as of Q2 2022.
- Glazer Capital reported no remaining Frazier Lifesciences Acquisition Corp Warrant position as of Q2 2022 after selling out during the quarter.
- Glazer Capital sold 36,150 Frazier Lifesciences Acquisition Corp Warrant shares in Q2 2022, an estimated $6K.
- Glazer Capital first reported a position in Frazier Lifesciences Acquisition Corp Warrant in Q4 2021 and held it in 2 quarters.
- Glazer Capital's Frazier Lifesciences Acquisition Corp Warrant position peaked at $26K in Q4 2021.
- 30 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corp Warrant as of Q2 2022.
Based on Glazer Capital's 13F filing for Q2 2022, filed 15 Aug 2022.